SBS 1000
Alternative Names: MP 1000 - Sparian Biosciences; SBS-1000Latest Information Update: 02 Dec 2024
Price :
$50 *
At a glance
- Originator Sparian Biosciences
- Class Amides; Analgesics; Aromatic hydrocarbons; Epoxy compounds
- Mechanism of Action Opioid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Acute pain
- Preclinical Pain
Most Recent Events
- 14 Nov 2024 Sparian Biosciences completes a phase I trial in Acute pain (In volunteers) in USA (IV) (NCT05721287)
- 12 Nov 2024 Safety and pharmacodynamics data from a phase-I clinical trials in Acute pain released by Sparian Biosciences
- 15 Feb 2023 Preclinical trials in Acute pain in USA (IV), prior to February 2023